Doxycycline Changes the Transcriptome Profile of mIMCD3 Renal Epithelial Cells

Hyun Jun Jung1, Richard Coleman1, Owen M Woodward2

  • 1Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Frontiers in Physiology
|November 22, 2021
PubMed

Insights

Doxycycline (DOX) significantly alters gene expression in kidney cells, impacting cell proliferation and immune responses. This study provides a reference for understanding DOX effects in renal epithelial models.

Area of Science:

  • Molecular Biology
  • Renal Cell Biology
  • Genomics

Background:

  • Tetracycline-inducible systems are crucial for studying gene function in renal models.
  • The impact of doxycycline (DOX) on gene expression in these models is not fully understood.

Purpose of the Study:

  • To evaluate the effects of DOX on the transcriptome of mIMCD3 renal epithelial cells.
  • To establish a reference for DOX-mediated gene expression in kidney cells.

Main Methods:

  • mIMCD3 cells were treated with DOX for 3 or 6 days.
  • Genome-wide transcriptome profiles were analyzed using RNA-Seq.

Main Results:

  • DOX significantly altered 1,549 transcripts at 3 days and 2,643 transcripts at 6 days.
  • DOX decreased expression of signaling pathways (ERK, cAMP, Notch) involved in proliferation and differentiation.
  • Genes related to cell cycle, immune response, cytokines, and proliferation markers were downregulated.

Conclusions:

  • DOX profoundly impacts the renal epithelial transcriptome.
  • These findings offer insights into DOX responses and aid in designing DOX-inducible gene expression systems.

Related Concept Videos